Strategic partnership will focus on commercializing CELLSEARCH platform for COVID-19 related use cases, along with other COVID-19 related products BOLOGNA, Italy and HUNTINGDON VALLEY, Pa. and GAITHERSBURG, Md. — OpGen, Inc. (Nasdaq: OPGN), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, announced today that it has […]

CARLSBAD, Calif. — Thermo Fisher Scientific and First Genetics JCS, a manufacturer of diagnostic equipment and IVD kits intended to advance molecular genetic technologies into clinical practice, today announced a strategic partnership focused on commercializing next-generation sequencing (NGS)–based diagnostics in Russia. The agreement enables First Genetics to market its F-Genetics NGS System and IVD assays to Russian labs for […]

Modern Water is pleased to note that Integumen plc (“Integumen”), the Company’s reagent production agency partner, has entered into a collaboration agreement with Avacta plc (“Avacta”) for the evaluation of Avacta Affimers for the real-time identification of localised COVID-19 hotspots in wastewater, from which authorities can be alerted through Integumen’s real-time alert system to prevent […]

BUFFALO GROVE, Ill. — Sirius Automation Group, a market leader in benchtop Sample Preparation and Manipulation Laboratory Automation Workstations, is proud to announce their collaboration with Cerulean of Milton Keynes, United Kingdom. Cerulean will exclusively distribute worldwide outside the U.S., Sirius’ Automated Systems focusing on the UK and Ireland laboratory automation marketplace for implementations addressing […]

Maennedorf, Switzerland – Tecan is excited to announce an agreement with Thomas Scientific, a distributor of laboratory solutions and equipment, to support the sales of Tecan’s detection instruments and consumables portfolio in the US. This collaboration will allow Tecan to expand its presence for these product lines and reach a wider customer base across the […]

Inscopix today announced a collaboration with Bruker Corporation (NASDAQ: BRKR) for its new Multimodal Image Registration and Analysis (MIRA) platform. The platform and the collaboration will empower brain researchers to catalyze a more precise and comprehensive mechanistic understanding of the brain by seamlessly integrating one-photon imaging of neuronal activity using Inscopix’s miniature microscope-based nVistaTM and nVokeTM systems, […]

BALTIMORE, MD  – PathSensors Inc., a Baltimore biotechnology company, announced today that Massachusetts Institute of Technology (MIT) has expanded the company’s exclusive license to include clinical applications for CANARY™ technology. This broader license allows PathSensors to move into the point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast and highly sensitive assays will […]

— Multiplexed Target Enrichment Panel Sequences the Entire Viral Genome for High Coverage of Target Regions, Better Accuracy and Mutation Tracking — CleanPlex® Technology Produces High Quality Sequence-Ready Libraries with Excellent Sensitivity in Just 5.5 Hours Using an Efficient Workflow and Reducing Sequencing Costs by 99% — Paragon Genomics Is Developing New Barcoding Method Enabling […]

Recombinant engineered antibodies for COVID-19 diagnostics and therapeutic development   Redcar, UK. Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced a partnership with University of Zurich to offer synthetic nanobodies against the receptor binding domain (RBD) of SARS-CoV-2, the coronavirus that causes COVID-19. Under the partnership, the original nanobodies and newly […]

SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a partnership with Takeda Pharmaceutical Company Limited (Takeda) for access to proprietary phage display libraries for the discovery, validation and optimization of antibodies in Takeda’s pipeline […]